beta

DNA+

Ginkgo Bioworks Holdings Inc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

the organism company ginkgo bioworks engineers new organisms to solve challenges across a range of industries from fuels to pharmaceutical production. our biological engineers make use of an in-house pipeline of synthetic biology technologies to design, build, and test new organisms.

Market Cap: 2.01 Billion

Primary Exchange: NEW YORK STOCK EXCHANGE INC.

Website: ginkgobioworks.com

Shares Outstanding: 34.5 Million

Float: 0

Dividend: 0.0 (0.0%)

Beta: 3.334040168403087

Sector: Manufacturing

Industry: Biological Product (except Diagnostic) Manufacturing

Ethical Flags

Longest drawdown: 760 trading days

From: 2021-10-19 To: 2024-03-07

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud